Cleared Traditional

K923641 - IL TEST AST

K923641 is the FDA 510(k) clearance for IL TEST AST by Instrumentation Laboratory CO. It is a Class 2 Chemistry device (product code CIT) cleared through the Traditional 510(k) pathway after a 97-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1992
Decision
97d
Days
Class 2
Risk

K923641 is an FDA 510(k) clearance for the IL TEST AST, PN 35312. Classified as Nadh Oxidation/nad Reduction, Ast/sgot (product code CIT), Class II - Special Controls.

Submitted by Instrumentation Laboratory CO (Lexington, US). The FDA issued a Cleared decision on October 26, 1992 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1100 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Instrumentation Laboratory CO devices

Submission Details

510(k) Number K923641 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 21, 1992
Decision Date October 26, 1992
Days to Decision 97 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
9d slower than avg
Panel avg: 88d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIT Nadh Oxidation/nad Reduction, Ast/sgot
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIT Nadh Oxidation/nad Reduction, Ast/sgot

All 84
Devices cleared under the same product code (CIT) and FDA review panel - the closest regulatory comparables to K923641.
OLYMPUS ASPARTATE AMINOTRANSFERASE REAGENT
K925155 · Olympus Corp. · Jan 1993
ROCHE REAGENT FOR AST
K924244 · Roche Diagnostic Systems, Inc. · Jan 1993
AST (GOT) - ASPARTATE AMINOTRANSFERASE
K923505 · Randox Laboratories, Ltd. · Nov 1992
SYSTAMATE ASPARTATE AMINOTRANSFERASE TEST TECHNICO
K922857 · Em Diagnostic Systems, Inc. · Sep 1992
OLYMPUS ASPARTATE AMINOTRANSFERASE REAGENT
K922885 · Olympus Corp. · Jul 1992
MILES ASPARTATE AMINOTRANSFERASE SERA-PAK METHOD
K920336 · Heraeus Kulzer, Inc. · Mar 1992